S-3 filed Jun 2, 2026 at 16:39 ET
Forte Biosciences filed a universal shelf registration statement on Form S-3 to offer and sell up to $500,000,000 in securities (common stock, preferred stock, debt securities, depositary shares, warrants, subscription rights, purchase contracts, and units) from time to time. The company has a market cap of $342M, meaning the shelf represents ~146% of current market cap, signaling massive potential dilution. The filing is a placeholder, no specific offering is announced, but the company's cash burn is accelerating (Q1 2026 net loss of $22.1M vs $15.7M a year ago), and cash & equivalents fell from $77.0M to $58.2M in Q1 2026, suggesting the company will likely tap this shelf soon to fund operations.